The Cannabis ETF (THCX)
ARCA ARCA Primary 
Best U.S. Cannabis Stocks to Watch in February: Key Players in the Market
The U.S. cannabis industry continues to expand as more states legalize marijuana. In 2023, the industry generated over $34 billion in sales, with projections reaching $50 billion by 2028. Recently, federal lawmakers revisited discussions on banking reform, which could improve cannabis companies' access to capital. Additionally, states like Florida and Pennsylvania are considering new recreational legalization measures, potentially boosting the market. Investors remain focused on companies with strong financials and strategic growth plans. However, stock prices remain volatile due to regulatory uncertainty. To navigate this sector, traders must watch price action and market trends carefully.
Canopy Growth: Q3 Earnings Shows Improvement But Cannabis Sector Remains Weak
Canopy Growth recently reported improved Q3-2025 financial results. They expect continued growth across operating segments. The company's stock price is down 46% over the last twelve months.
2 Cannabis Stocks For Potential Market Movers This Year
Investing in cannabis stocks inside of a volatile sector has its ups and downs. There is much to consider and watch for when building your portfolio. The more diversified your marijuana stocks portfolio is the better at being more profitable. It can be tricky at times to know when to enter and exit trade and which publicly traded cannabis companies. Some tips on this would be to do your research and look for certain factors. For example, check out any recent news or financials.
Here Is How Marijuana Stocks Are Impact By The Cannabis Industry
The growth of the cannabis industry is set to have a profound impact on marijuana stocks in 2025. With an increasing number of states and countries legalizing cannabis, the market is expanding rapidly. This has led to the potential of creating lucrative investment opportunities. Cannabis stocks trade with high levels of volatility. This has made it tough to gauge market patterns and trends as things can shift without warning. For some time many depend on the volatility to be able to make a profit.
Mid-February Watchlist: Leading Cannabis REITs for Real Estate Growth
The U.S. cannabis industry continues expanding, creating opportunities for real estate investment trusts (REITs) that finance dispensaries and cultivation facilities. The legal cannabis market is projected to reach $41.5 billion by 2025, growing at a rapid pace. Currently, 38 states allow medical marijuana, while 24 states have legalized recreational use. This expansion fuels demand for real estate, making cannabis REITs essential for industry growth. Recent legalization efforts in Florida and Pennsylvania could further boost the market. However, federal cannabis reform remains uncertain, causing volatility in cannabis-related stocks. Investors must carefully analyze market conditions before making decisions.
Cannabis REITs: Less Risky Choices In A Risky Sector
Cannabis stocks have underperformed due to unmet regulatory expectations and high leverage, making them risky investments despite low valuations, according to Julian Lin. NewLake Capital remains attractive due to its lack of debt and high yield, despite tenant issues similar to those faced by Innovative Industrial Properties.
Aurora Cannabis Skyrockets After Earnings: Should You Buy Into the Rally?
The year is a more than a month old, but Aurora Cannabis (ACB -2.87%) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year began -- and that rally began only a few days ago.
Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years
On Tuesday, Cannabis producer Organigram Holdings Inc OGI reported first-quarter 2025 gross sales of CA$66.8 million, up 19% year-over-year, beating the consensus of CA$65.4 million.
High-Potential Ancillary Cannabis Stocks to Watch in February 2025
The U.S. cannabis industry continues to expand, creating strong opportunities for ancillary companies that support dispensaries and cultivators. In 2024, legal cannabis sales in the U.S. exceeded $35 billion, with projections reaching over $40 billion by 2025. Ancillary businesses that provide technology, equipment, and services benefit from this rapid growth without facing the same legal challenges as plant-touching companies. Recently, federal legalization talks have gained momentum, with lawmakers pushing for banking reform and rescheduling cannabis. If these changes occur, more businesses could enter the market, boosting demand for ancillary services. Investors looking for exposure to the sector should watch these stocks closely.
Aurora Cannabis: Strong Buy On Blowout Results And Constructive Outlook
Last week, Aurora Cannabis reported blowout Q3/FY2025 results with sales, gross margins, profitability, and free cash flow reaching new all-time highs. As a leader in the medical cannabis space, the company is enjoying premium margins. Following the descheduling of cannabis in Germany last year, sales in Europe have increased substantially. Cash, restricted cash and cash equivalents increased to $180.2 million. The company's core cannabis operations remain debt free.
Top U.S. Cannabis Stocks to Watch This Month: February 2025 Picks
The U.S. cannabis industry continues expanding, with total legal sales expected to reach $40 billion by 2025. Currently, 38 states have legalized medical marijuana, and 24 states allow recreational use. Recent headlines suggest momentum for federal reform, with lawmakers pushing for banking access and interstate commerce. Many investors are closely watching top marijuana stocks for potential growth opportunities. However, cannabis stocks remain highly volatile, making proper risk management crucial. Traders often use technical analysis to identify entry points and manage downside risk. Key indicators like moving averages, RSI, and volume trends help assess momentum.
Why Is Canada-Based Cannabis Firm Canopy Growth Stock Trading Lower On Friday?
On Friday, Canopy Growth Corporation CGC reported third-quarter 2025 sales of CA$74.76 million, down from CA$78.51 million a year ago, beating the consensus of CA$69.11 million.
